Pedro Laires

Pedro Laires serves as a Visiting Assistant Professor in Epidemiology at the National School of Public Health (Escola Nacional de Saúde Pública - ENSP) of Universidade Nova de Lisboa and is a member of the Center for Public Health Research (CISP) and Comprehensive Health Research Centre (CHRC). He holds a PhD in Epidemiology, Public Health and Health Economics & Outcomes Research from the University of Lisbon, with his doctoral work focusing on "The Impact of Rheumatic Diseases and Early Retirement".

Dr. Laires maintains a dual career path, currently serving as Global Director of Epidemiology (Real-World Evidence) at Novartis while continuing his academic work. His professional history includes significant industry experience as Research Manager in Health Economics & Outcomes Research at Novartis (2017-2020) in the Neurology area and management positions in Outcomes Research at Merck.

His research program spans multiple critical areas in public health:

• Impact of multimorbidity on early retirement
• Drug effectiveness studies (pharmacoepidemiology)
• Health Economics & Outcomes Research (HEOR)
• Real-World Evidence (RWE) generation
• Epidemiological studies including the EpiReumaPt project

Dr. Laires' scholarly output demonstrates methodological expertise across diverse public health challenges, with recent publications examining healthcare utilization patterns during the pandemic, chronic disease management, and workplace health impacts. His research consistently applies epidemiological methods to generate evidence relevant to clinical practice and health policy decision-making.

His academic contributions are complemented by his industry leadership in developing real-world evidence strategies that bridge research and practical healthcare applications, positioning him as a significant contributor to both academic epidemiology and pharmaceutical outcomes research.